Citi Provides Color on Thomson Reuters, Hold
Citi provided color on Thomson Reuters (NYSE: TRI) as the company announced its plans to sell its Healthcare business by the end of this year.
In a research report published today, Citi states, "Thomson Reuters announced that it intends to divest its Healthcare business from its "Health & Science" division by the end of this year. CEO, Tom Glocer believes they can achieve better "all-in return" for shareholders by divesting the business and investing in their core franchises, where they see "significant opportunities for future growth and profitability"."
At the moment, Citi has a Hold rating and a price target of $40 on the company's stock.
On Monday, Thomson Reuters lost 0.61% of its value to close the day at $37.60.
© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.